FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2239952012> ?p ?o ?g. }

• W2239952012 endingPage "7" @default.
• W2239952012 startingPage "1" @default.
• W2239952012 abstract "To evaluate the long-term safety and seizure outcome in Japanese patients with Lennox-Gastaut syndrome (LGS) receiving adjunctive rufinamide therapy.We conducted an open-label extension study following a 12-week multicenter, randomized, double-blind, placebo-controlled study of adjunctive rufinamide therapy in Japanese patients with LGS. Fifty-four patients participated in the extension study. Seizure frequency was evaluated until 52 weeks after the start of the extension study. Adverse events (AEs) were evaluated throughout both studies.Of the 54 patients, 41 (75.9%) completed the extension study. The median duration of exposure to rufinamide was 818.0 days in all 54 patients, and 38 patients (70.4%) received rufinamide for 2 years or more. The median percent change in the frequency of tonic-atonic seizures relative to the frequency at the start of the double-blind study was -39.3% (12 weeks), -40.6% (24 weeks), -46.8% (32 weeks), -47.6% (40 weeks), and -36.1% (52 weeks). Reduction of total seizure frequency was also maintained until 52 weeks. Frequent treatment-related AEs were somnolence (20.4%), decreased appetite (16.7%), transient seizure aggravation including status epilepticus (13.0%), vomiting (11.1%), and constipation (11.1%). Adverse events were mild or moderate, except for transient seizure aggravation in three patients. Adverse events resulting in discontinuation of rufinamide were decreased appetite, drug eruption, and worsening of underlying autism. When clinically notable weight loss was defined as a decrease ≥ 7% relative to baseline, 22 patients (40.7%) experienced weight loss at least once during long-term observation, although weight loss was reported as an AE in only three patients.This study demonstrated a long-term benefit of rufinamide as adjunctive therapy for Japanese patients with LGS. Exacerbation of seizures and decreased appetite/weight loss should be monitored carefully." @default.
• W2239952012 created "2016-06-24" @default.
• W2239952012 creator A5018331403 @default.
• W2239952012 creator A5040378349 @default.
• W2239952012 creator A5043724826 @default.
• W2239952012 creator A5051224602 @default.
• W2239952012 creator A5066198640 @default.
• W2239952012 creator A5078597637 @default.
• W2239952012 date "2016-03-01" @default.
• W2239952012 modified "2023-10-16" @default.
• W2239952012 title "Long-term safety and seizure outcome in Japanese patients with Lennox–Gastaut syndrome receiving adjunctive rufinamide therapy: An open-label study following a randomized clinical trial" @default.
• W2239952012 cites W1480991552 @default.
• W2239952012 cites W1579311408 @default.
• W2239952012 cites W1604250740 @default.
• W2239952012 cites W1964684758 @default.
• W2239952012 cites W1967440903 @default.
• W2239952012 cites W1995799480 @default.
• W2239952012 cites W2000186185 @default.
• W2239952012 cites W2020733752 @default.
• W2239952012 cites W2037608619 @default.
• W2239952012 cites W2044362640 @default.
• W2239952012 cites W2061457158 @default.
• W2239952012 cites W2061631774 @default.
• W2239952012 cites W2064392570 @default.
• W2239952012 cites W2070274272 @default.
• W2239952012 cites W2080289801 @default.
• W2239952012 cites W2090699703 @default.
• W2239952012 cites W2135065143 @default.
• W2239952012 cites W2137728866 @default.
• W2239952012 cites W2150292807 @default.
• W2239952012 cites W2165165265 @default.
• W2239952012 cites W2316322329 @default.
• W2239952012 cites W4236676256 @default.
• W2239952012 doi "https://doi.org/10.1016/j.eplepsyres.2016.01.002" @default.
• W2239952012 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26827266" @default.
• W2239952012 hasPublicationYear "2016" @default.
• W2239952012 type Work @default.
• W2239952012 sameAs 2239952012 @default.
• W2239952012 citedByCount "30" @default.
• W2239952012 countsByYear W22399520122017 @default.
• W2239952012 countsByYear W22399520122018 @default.
• W2239952012 countsByYear W22399520122019 @default.
• W2239952012 countsByYear W22399520122020 @default.
• W2239952012 countsByYear W22399520122021 @default.
• W2239952012 countsByYear W22399520122022 @default.
• W2239952012 countsByYear W22399520122023 @default.
• W2239952012 crossrefType "journal-article" @default.
• W2239952012 hasAuthorship W2239952012A5018331403 @default.
• W2239952012 hasAuthorship W2239952012A5040378349 @default.
• W2239952012 hasAuthorship W2239952012A5043724826 @default.
• W2239952012 hasAuthorship W2239952012A5051224602 @default.
• W2239952012 hasAuthorship W2239952012A5066198640 @default.
• W2239952012 hasAuthorship W2239952012A5078597637 @default.
• W2239952012 hasBestOaLocation W22399520121 @default.
• W2239952012 hasConcept C118552586 @default.
• W2239952012 hasConcept C126322002 @default.
• W2239952012 hasConcept C141071460 @default.
• W2239952012 hasConcept C187212893 @default.
• W2239952012 hasConcept C197934379 @default.
• W2239952012 hasConcept C2778186239 @default.
• W2239952012 hasConcept C2778715236 @default.
• W2239952012 hasConcept C2779034229 @default.
• W2239952012 hasConcept C2779307984 @default.
• W2239952012 hasConcept C2780852908 @default.
• W2239952012 hasConcept C3018162438 @default.
• W2239952012 hasConcept C42219234 @default.
• W2239952012 hasConcept C71924100 @default.
• W2239952012 hasConceptScore W2239952012C118552586 @default.
• W2239952012 hasConceptScore W2239952012C126322002 @default.
• W2239952012 hasConceptScore W2239952012C141071460 @default.
• W2239952012 hasConceptScore W2239952012C187212893 @default.
• W2239952012 hasConceptScore W2239952012C197934379 @default.
• W2239952012 hasConceptScore W2239952012C2778186239 @default.
• W2239952012 hasConceptScore W2239952012C2778715236 @default.
• W2239952012 hasConceptScore W2239952012C2779034229 @default.
• W2239952012 hasConceptScore W2239952012C2779307984 @default.
• W2239952012 hasConceptScore W2239952012C2780852908 @default.
• W2239952012 hasConceptScore W2239952012C3018162438 @default.
• W2239952012 hasConceptScore W2239952012C42219234 @default.
• W2239952012 hasConceptScore W2239952012C71924100 @default.
• W2239952012 hasLocation W22399520121 @default.
• W2239952012 hasLocation W22399520122 @default.
• W2239952012 hasOpenAccess W2239952012 @default.
• W2239952012 hasPrimaryLocation W22399520121 @default.
• W2239952012 hasRelatedWork W2040021578 @default.
• W2239952012 hasRelatedWork W2053239343 @default.
• W2239952012 hasRelatedWork W2089104512 @default.
• W2239952012 hasRelatedWork W2104761597 @default.
• W2239952012 hasRelatedWork W2126552437 @default.
• W2239952012 hasRelatedWork W2595354173 @default.
• W2239952012 hasRelatedWork W2766414905 @default.
• W2239952012 hasRelatedWork W3121186989 @default.
• W2239952012 hasRelatedWork W4233897828 @default.
• W2239952012 hasRelatedWork W8168635 @default.
• W2239952012 hasVolume "121" @default.
• W2239952012 isParatext "false" @default.
• W2239952012 isRetracted "false" @default.
• W2239952012 magId "2239952012" @default.

• next